Computational Drug Repurposing for Antituberculosis Therapy: Discovery of Multi-Strain Inhibitors

Computational Drug Repurposing for Antituberculosis Therapy: Discovery of Multi-Strain Inhibitors

Tuberculosis remains the most afflicting infectious disease known by humankind, with one quarter of the population estimated to have it in the latent state. Discovering antituberculosis drugs is a challenging, complex, expensive, and time-consuming task. To overcome the substantial costs and acceler...

Full description

Bibliographic Details
Main Authors: Valeria V. Kleandrova, Marcus T. Scotti, Alejandro Speck-Planche
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Antibiotics
Subjects:
artificial neural networks
drug repurposing
ensemble
MLP
QSAR
tuberculosis
Online Access:https://www.mdpi.com/2079-6382/10/8/1005

Similar Items

Similar Items